Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab

AIMS: Guidelines recommend targeting non-high-density lipoprotein cholesterol to reduce cardiovascular risk. We assessed the impact of baseline triglycerides on non-high-density lipoprotein cholesterol goal attainment in 10 phase 3 trials with alirocumab versus control (n = 4983). METHODS: Trials we...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Prev Cardiol
Autori principali: Vallejo-Vaz, Antonio J, Leiter, Lawrence A, Del Prato, Stefano, Taskinen, Marja-Riitta, Müller-Wieland, Dirk, Bujas-Bobanovic, Maja, Letierce, Alexia, Mandel, Jonas, Samuel, Rita, Ray, Kausik K
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2020
Soggetti:
Full Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7549294/
https://ncbi.nlm.nih.gov/pubmed/32089006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2047487320905185
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi